
| ROI Name | ∑ In  | % In  | log ratio  | ∑ Out  | % Out  | 
|---|---|---|---|---|---|
| MB_ML_R | 409 | 37.4% | 0.96 | 794 | 43.5% | 
| CRE_R | 278 | 25.4% | 1.11 | 601 | 32.9% | 
| MB_PED_R | 163 | 14.9% | 0.74 | 273 | 15.0% | 
| MB_CA_R | 172 | 15.7% | -2.30 | 35 | 1.9% | 
| SCL_R | 48 | 4.4% | 0.27 | 58 | 3.2% | 
| SMP_R | 17 | 1.6% | 1.23 | 40 | 2.2% | 
| PLP_R | 6 | 0.5% | 1.66 | 19 | 1.0% | 
| SIP_R | 2 | 0.2% | 1.32 | 5 | 0.3% | 
| upstream partner  | # | NT | conns KCg-s2  | % In  | CV | 
|---|---|---|---|---|---|
| KCg-d (R) | 107 | ACh | 367 | 36.5% | 1.3 | 
| KCg-m (R) | 172 | ACh | 212 | 21.1% | 0.5 | 
| KCg-s2 (R) | 1 | ACh | 93 | 9.2% | 0.0 | 
| VP3+_vPN (R) | 1 | GABA | 57 | 5.7% | 0.0 | 
| KCg-s1 (R) | 1 | ACh | 27 | 2.7% | 0.0 | 
| SLP184 (R) | 1 | ACh | 24 | 2.4% | 0.0 | 
| VP2_adPN (R) | 1 | ACh | 19 | 1.9% | 0.0 | 
| PAM08 (R) | 10 | DA | 18 | 1.8% | 0.7 | 
| PPL103 (R) | 1 | DA | 16 | 1.6% | 0.0 | 
| APL (R) | 1 | GABA | 16 | 1.6% | 0.0 | 
| PPL103 (L) | 1 | DA | 10 | 1.0% | 0.0 | 
| DPM (R) | 1 | DA | 10 | 1.0% | 0.0 | 
| CB4219 (R) | 3 | ACh | 10 | 1.0% | 0.4 | 
| aMe26 (R) | 1 | ACh | 9 | 0.9% | 0.0 | 
| PAM07 (R) | 5 | DA | 9 | 0.9% | 0.6 | 
| MBON05 (L) | 1 | Unk | 8 | 0.8% | 0.0 | 
| PPL101 (R) | 1 | DA | 8 | 0.8% | 0.0 | 
| KCapbp-ap1 (R) | 6 | ACh | 7 | 0.7% | 0.3 | 
| OA-VPM3 (L) | 1 | OA | 5 | 0.5% | 0.0 | 
| KCab-p (R) | 5 | ACh | 5 | 0.5% | 0.0 | 
| M_l2PNm16 (R) | 2 | ACh | 4 | 0.4% | 0.5 | 
| PAM05 (R) | 4 | DA | 4 | 0.4% | 0.0 | 
| VP1m+VP5_ilPN (L) | 1 | ACh | 3 | 0.3% | 0.0 | 
| PPL102 (L) | 1 | DA | 3 | 0.3% | 0.0 | 
| CB1321 (R) | 2 | ACh | 3 | 0.3% | 0.3 | 
| VP1m+_lvPN (R) | 2 | Glu | 3 | 0.3% | 0.3 | 
| PAM08 (L) | 3 | DA | 3 | 0.3% | 0.0 | 
| PAM12 (R) | 3 | DA | 3 | 0.3% | 0.0 | 
| OA-VUMa2 (M) | 1 | OA | 2 | 0.2% | 0.0 | 
| LHPV6c1 (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| VP1l+VP3_ilPN (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| mALB1 (L) | 1 | GABA | 2 | 0.2% | 0.0 | 
| CB4218 (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| MTe37 (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| MBON09 (R) | 2 | GABA | 2 | 0.2% | 0.0 | 
| CB3206 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| aMe12 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| OA-VPM4 (L) | 1 | OA | 1 | 0.1% | 0.0 | 
| LHPV6m1 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| SMP376 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| PAM12 (L) | 1 | DA | 1 | 0.1% | 0.0 | 
| MBON35 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CB1956 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CRE048 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| VC5_lvPN (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| V_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| PAM07 (L) | 1 | DA | 1 | 0.1% | 0.0 | 
| MBON10 (R) | 1 | GABA | 1 | 0.1% | 0.0 | 
| LHAV3q1 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| SMP541 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| FB4K (L) | 1 | 5-HT | 1 | 0.1% | 0.0 | 
| CSD (L) | 1 | 5-HT | 1 | 0.1% | 0.0 | 
| SMP568 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CRE060,CRE067 (R) | 1 | Unk | 1 | 0.1% | 0.0 | 
| M_smPNm1 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| MBON33 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| DN1a (R) | 1 | Unk | 1 | 0.1% | 0.0 | 
| CRE024 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CRE078 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| VP1m+VP5_ilPN (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CB1454 (R) | 1 | GABA | 1 | 0.1% | 0.0 | 
| DA1_lPN (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| PPL101 (L) | 1 | DA | 1 | 0.1% | 0.0 | 
| LHPD5c1 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| LHPV4c3, LHPV4c4 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| PAM05 (L) | 1 | DA | 1 | 0.1% | 0.0 | 
| SMP177 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CB1079 (R) | 1 | GABA | 1 | 0.1% | 0.0 | 
| VP1l+VP3_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| VP3+VP1l_ivPN (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| MBON26 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| downstream partner  | # | NT | conns KCg-s2  | % Out  | CV | 
|---|---|---|---|---|---|
| KCg-d (R) | 102 | ACh | 316 | 25.8% | 1.5 | 
| KCg-m (R) | 170 | ACh | 209 | 17.1% | 0.4 | 
| MBON05 (L) | 1 | Unk | 94 | 7.7% | 0.0 | 
| KCg-s2 (R) | 1 | ACh | 93 | 7.6% | 0.0 | 
| PAM08 (R) | 17 | DA | 73 | 6.0% | 1.0 | 
| APL (R) | 1 | GABA | 38 | 3.1% | 0.0 | 
| MBON09 (R) | 2 | GABA | 37 | 3.0% | 0.0 | 
| PAM07 (R) | 9 | DA | 34 | 2.8% | 0.7 | 
| MBON04 (L) | 1 | Glu | 31 | 2.5% | 0.0 | 
| MBON11 (R) | 1 | GABA | 29 | 2.4% | 0.0 | 
| PAM08 (L) | 11 | DA | 23 | 1.9% | 0.5 | 
| KCg-s1 (R) | 1 | ACh | 19 | 1.6% | 0.0 | 
| MBON21 (R) | 1 | ACh | 17 | 1.4% | 0.0 | 
| DPM (R) | 1 | DA | 14 | 1.1% | 0.0 | 
| MBON33 (R) | 1 | ACh | 14 | 1.1% | 0.0 | 
| PPL102 (L) | 1 | DA | 12 | 1.0% | 0.0 | 
| CRE048 (R) | 1 | Glu | 11 | 0.9% | 0.0 | 
| PPL103 (R) | 1 | DA | 10 | 0.8% | 0.0 | 
| PAM05 (L) | 3 | DA | 9 | 0.7% | 0.7 | 
| PAM12 (R) | 4 | DA | 9 | 0.7% | 0.6 | 
| PPL101 (R) | 1 | DA | 8 | 0.7% | 0.0 | 
| PAM05 (R) | 2 | DA | 8 | 0.7% | 0.5 | 
| PPL101 (L) | 1 | DA | 7 | 0.6% | 0.0 | 
| PPL103 (L) | 1 | DA | 7 | 0.6% | 0.0 | 
| LHPV3c1 (R) | 1 | ACh | 6 | 0.5% | 0.0 | 
| SMP261 (R) | 3 | ACh | 5 | 0.4% | 0.3 | 
| MBON35 (R) | 1 | ACh | 4 | 0.3% | 0.0 | 
| PAM02 (R) | 2 | DA | 4 | 0.3% | 0.5 | 
| SMP262 (R) | 2 | ACh | 4 | 0.3% | 0.0 | 
| MBON27 (R) | 1 | ACh | 3 | 0.2% | 0.0 | 
| MBON30 (R) | 1 | Glu | 3 | 0.2% | 0.0 | 
| MBON12 (R) | 1 | ACh | 3 | 0.2% | 0.0 | 
| aMe12 (R) | 2 | ACh | 3 | 0.2% | 0.3 | 
| FB4Y (R) | 2 | 5-HT | 3 | 0.2% | 0.3 | 
| KCapbp-ap1 (R) | 3 | ACh | 3 | 0.2% | 0.0 | 
| LAL159 (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| SMP108 (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| SLP184 (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| MBON20 (R) | 1 | GABA | 2 | 0.2% | 0.0 | 
| MBON26 (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| MBON29 (R) | 1 | ACh | 2 | 0.2% | 0.0 | 
| MBON32 (R) | 1 | Unk | 2 | 0.2% | 0.0 | 
| OA-VPM4 (L) | 1 | OA | 2 | 0.2% | 0.0 | 
| PAM12 (L) | 1 | DA | 2 | 0.2% | 0.0 | 
| KCab-p (R) | 2 | ACh | 2 | 0.2% | 0.0 | 
| PAM07 (L) | 2 | DA | 2 | 0.2% | 0.0 | 
| DL3_lPN (R) | 2 | ACh | 2 | 0.2% | 0.0 | 
| FB4K (R) | 1 | Unk | 1 | 0.1% | 0.0 | 
| PPL202 (R) | 1 | DA | 1 | 0.1% | 0.0 | 
| LHPV6g1 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| LHPD2c7 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| CB4242 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| MTe37 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| PAM06 (R) | 1 | DA | 1 | 0.1% | 0.0 | 
| MTe24 (R) | 1 | Unk | 1 | 0.1% | 0.0 | 
| PS292 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| VP3+VP1l_ivPN (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CB3077 (R) | 1 | GABA | 1 | 0.1% | 0.0 | 
| aMe22 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| LAL145 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| MBON23 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| SMP152 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| PAM01 (R) | 1 | Unk | 1 | 0.1% | 0.0 | 
| LAL198 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| PS291 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| MBON01 (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| LHPV8a1 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| OA-VPM3 (L) | 1 | OA | 1 | 0.1% | 0.0 | 
| CRE068 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| LHCENT3 (R) | 1 | GABA | 1 | 0.1% | 0.0 | 
| CB3770 (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| SMP421 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| SLP462 (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| CRE060,CRE067 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CRE024 (L) | 1 | Unk | 1 | 0.1% | 0.0 | 
| LAL100 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| MBON09 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| SLP003 (R) | 1 | GABA | 1 | 0.1% | 0.0 | 
| LHAV3q1 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CB1063 (R) | 1 | Glu | 1 | 0.1% | 0.0 | 
| LHPV7a2 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| LTe72 (R) | 1 | ACh | 1 | 0.1% | 0.0 | 
| SMP341 (R) | 1 | ACh | 1 | 0.1% | 0.0 |